Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous ADMSCS and SVF for Critical Limb Ischemia
NCT02145897Phase 2Unknown
- Sponsor
- Kasiak Research Pvt Ltd.
- Start
- Aug 2014
- Primary completion
- Aug 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose derived mesenchymal stem cells, autologous adipose-derived stromal vascular fraction in critical limb ischemia (CLI), sponsored by Kasiak Research Pvt Ltd.. Status: unknown.
02
Drugs
autologous adipose derived mesenchymal stem cellsautologous adipose-derived stromal vascular fraction
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT02145897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145897.